Effect of granulocyte colony-stimulating factor on toxicities after CAR T cell therapy for lymphoma and myeloma - Poll - MDSpire

Effect of granulocyte colony-stimulating factor on toxicities after CAR T cell therapy for lymphoma and myeloma

  • By

  • Kevin Charles Miller

  • Patrick Connor Johnson

  • Jeremy S. Abramson

  • Jacob D. Soumerai

  • Andrew J. Yee

  • Andrew R. Branagan

  • Elizabeth K. O’Donnell

  • Anna Saucier

  • Caron A. Jacobson

  • Matthew J. Frigault

  • Noopur S. Raje

  • November 1, 2022

  • 0 min

Share

Original Source(s)

Effect of granulocyte colony-stimulating factor on toxicities after CAR T cell therapy for lymphoma and myeloma

  • by Kevin Charles Miller, Patrick Connor Johnson, Jeremy S. Abramson, Jacob D. Soumerai, Andrew J. Yee, Andrew R. Branagan, Elizabeth K. O’Donnell, Anna Saucier, Caron A. Jacobson, Matthew J. Frigault, Noopur S. Raje

  • November 1, 2022

Related Content

Blocking CD30 on CD19 CAR T cells augments their functional capacities against B-cell leukemia/lymphoma

Prognostic Impact of Early Disease Progression and Early Mortality in Patients with Multiple Myeloma: A Real-World Cohort Study

Case Report: Extranodal marginal zone B-cell lymphoma in the lateral ventricle: literature review